ArticleTranslational lung cancer research2025
Immunohistochemical analysis of p53 and LKB1 as predictive biomarkers of immune checkpoint inhibitor response in non-small cell lung cancer.
Kazuo Tsuchiya et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.